INNT
TOTAL INVALIDATION PROCESSED BY THE IB
05/31/2025
Back to search
Official data from USPTO
ZEPTISO HYDROCORTISONE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
06/01/2025
Trademark type
Combined
Nice classes
5
Filing date
12/12/2016
Registration date
11/14/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/31/2024
Last transaction
06/01/2025
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
33
Owner location
FR
Examiner
THOMAS,AMY E
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized word "ZEPTISO" with "ZEP" in gray and "TISO" in black. Underneath is the orange word "HYDROCORTISONE". To the upper right of the mark is a red Greek cross comprised of two angle shapes overlapping with white outlining inside an orange circle. The background is not claimed as a feature of the mark.
Holders and representatives
Holders
CROSSJECT
Representatives
Brooks R. Bruneau FisherBroyles, LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations containing hydrocortisone for endocrinologic use only
Publications
History of USPTO decisions and trademark events.
28 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
04/14/2025
XXCR
GENERIC MADRID TRANSACTION CREATED
04/14/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
01/31/2025
C71T
CANCELLED SECTION 71
05/31/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
11/14/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/13/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/21/2018
FIMP
FINAL DISPOSITION PROCESSED
02/21/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/14/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
11/14/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/29/2017
PUBO
PUBLISHED FOR OPPOSITION
08/29/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/09/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/25/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/24/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/24/2017
ALIE
ASSIGNED TO LIE
07/18/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/12/2017
RFNT
REFUSAL PROCESSED BY IB
05/05/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/17/2017
RFRR
REFUSAL PROCESSED BY MPU
04/17/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/14/2017
MAFR
APPLICATION FILING RECEIPT MAILED
04/14/2017
CNRT
NON-FINAL ACTION WRITTEN
04/13/2017
DOCK
ASSIGNED TO EXAMINER
04/10/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/10/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/06/2017
Continuous trademark protection
Get notified about every new filing that threatens ZEPTISO HYDROCORTISONE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.